Health Catalyst, Inc. — Director's Dealing 2021

Jun 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-06-07

Reporting Person: Horstmeier Paul (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-07	Common Stock	M	6063.00	$15.84	Acquired	121764.00	Direct
2021-06-07	Common Stock	S	1202.00	$53.7724	Disposed	120562.00	Direct
2021-06-07	Common Stock	S	300.00	$54.65	Disposed	120262.00	Direct
2021-06-07	Common Stock	S	4516.00	$55.8691	Disposed	115746.00	Direct
2021-06-07	Common Stock	S	45.00	$56.3671	Disposed	115701.00	Direct
2021-06-07	Common Stock	S	545.00	$53.7329	Disposed	115156.00	Direct
2021-06-07	Common Stock	S	200.00	$54.755	Disposed	114956.00	Direct
2021-06-07	Common Stock	S	1827.00	$55.8986	Disposed	113129.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-07	Stock Option (Right to Buy)	$15.84	M	6063.00	Disposed	2029-02-05	Common Stock (6063.00)	Direct

Footnotes

F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.

F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.23 to $54.10, inclusive.

F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.23 to $54.95, inclusive.

F4: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.30 to $56.27, inclusive.

F5: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $56.36 to $56.40, inclusive.

F6: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.25 to $54.03, inclusive.

F7: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.27 to $55.24, inclusive.

F8: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.43 to $56.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (8).

F9: 25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.